Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder

Differences in premorbid functioning may explain apparent differences in neurocognitive function between schizophrenia spectrum patients using cannabis or not. The findings suggest that illness-related traits present early in life can affect both later cannabis use and neurocognition, probably by complex mechanisms.